Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura E Pascal

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Asian Journal of Andrology|October 1, 2013
Virtual drug design: Skp1-Skp2 inhibition targets cancer stem cellsLaura E Pascal, Zhou Wang
Toxicology Letters|October 19, 2006
Activation of MAP kinases by hexavalent chromium, manganese and nickel in human lung epithelial cellsDaniel M Tessier, Laura E Pascal
Toxicology Letters|February 6, 2004
Cytotoxicity of chromium and manganese to lung epithelial cells in vitroLaura E Pascal, Daniel M Tessier
American Journal of Clinical and Experimental Urology|September 20, 2021
The classical and updated models of androgen receptor nucleocytoplasmic traffickingRyan Cole, Laura E Pascal, Zhou Wang
The Journal of Pharmacology and Experimental Therapeutics|April 27, 2025
Regulation of glucocorticoid receptor nuclear localization in prostate cancer cellsGuang Chen, Shidong Lv, Laura E Pascal, et al.
Translational Andrology and Urology|July 22, 2014
Androgen receptor gene mutation, rearrangement, polymorphismKurtis Eisermann, Dan Wang, Yifeng Jing, et al.
Asian Journal of Andrology|April 25, 2014
Improving intermittent androgen deprivation therapy: lessons learned from basic and translational researchRahul A Parikh, Laura E Pascal, Benjamin J Davies, et al.
Cancer Biomarkers : Section a of Disease Markers|November 25, 2011
Stromal-epithelial interactions in early neoplasiaAlvin Y Liu, Laura E Pascal, Ricardo Z Vêncio, et al.
American Journal of Clinical and Experimental Urology|November 7, 2014
Growth of LAPC4 prostate cancer xenograft tumor is insensitive to 5α-reductase inhibitor dutasterideRaquel Ramos Garcia, Khalid Z Masoodi, Laura E Pascal, et al.
Molecular Cancer Therapeutics|January 21, 2022
(+)-JJ-74-138 is a Novel Noncompetitive Androgen Receptor AntagonistRyan N Cole, Wei Chen, Laura E Pascal, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Asian Journal of Andrology|October 1, 2013
Virtual drug design: Skp1-Skp2 inhibition targets cancer stem cellsLaura E Pascal, Zhou Wang
Toxicology Letters|October 19, 2006
Activation of MAP kinases by hexavalent chromium, manganese and nickel in human lung epithelial cellsDaniel M Tessier, Laura E Pascal
Toxicology Letters|February 6, 2004
Cytotoxicity of chromium and manganese to lung epithelial cells in vitroLaura E Pascal, Daniel M Tessier
American Journal of Clinical and Experimental Urology|September 20, 2021
The classical and updated models of androgen receptor nucleocytoplasmic traffickingRyan Cole, Laura E Pascal, Zhou Wang
The Journal of Pharmacology and Experimental Therapeutics|April 27, 2025
Regulation of glucocorticoid receptor nuclear localization in prostate cancer cellsGuang Chen, Shidong Lv, Laura E Pascal, et al.
Translational Andrology and Urology|July 22, 2014
Androgen receptor gene mutation, rearrangement, polymorphismKurtis Eisermann, Dan Wang, Yifeng Jing, et al.
Asian Journal of Andrology|April 25, 2014
Improving intermittent androgen deprivation therapy: lessons learned from basic and translational researchRahul A Parikh, Laura E Pascal, Benjamin J Davies, et al.
Cancer Biomarkers : Section a of Disease Markers|November 25, 2011
Stromal-epithelial interactions in early neoplasiaAlvin Y Liu, Laura E Pascal, Ricardo Z Vêncio, et al.
American Journal of Clinical and Experimental Urology|November 7, 2014
Growth of LAPC4 prostate cancer xenograft tumor is insensitive to 5α-reductase inhibitor dutasterideRaquel Ramos Garcia, Khalid Z Masoodi, Laura E Pascal, et al.
Molecular Cancer Therapeutics|January 21, 2022
(+)-JJ-74-138 is a Novel Noncompetitive Androgen Receptor AntagonistRyan N Cole, Wei Chen, Laura E Pascal, et al.
Pageof 8